Control Group |
group 2 Conventional fluid therapy group |
The infusion started with ringer acetate solution after induction according to fasting period and maintenance and 3rd space loss according to surgical incision usually at the rate of 6–8 ml/kg/h according to the routine techniques by taking the parameters such as HR, mean arterial pressure (MAP), CVP and urine output into consideration |
all over surgical duration |
The infusion started with ringer acetate solution after induction according to fasting period and maintenance and 3rd space loss according to surgical incision usually at the rate of 6–8 ml/kg/h at colorectal surgery. The intraoperative fluid infusion according to the routine techniques by taking the parameters such as HR, mean arterial pressure (MAP), CVP and urine output into consideration. Hypotension defined as a condition in which the MAP was below 65 mmHg or 30% below the baseline MAP of the patient. In this case, the speed of crystalloid infusion was increased, colloid (6% hydroxy ethyl starch 130/ 0.4 ) infusion initiated and in case of hypotension persistence, blood were given according to blood loss and to maintain Hb level >10 g/ dl |
50 |
Active-Treatment of Control Group |
Experimental Group |
group 2 Goal directed fluid therapy group |
Basal stroke volume and stroke volume variation was recorded . 200 ml of Colloid 6% hydroxy ethyl starch 130/ 0.4 was infused over 10 minutes and stroke volume response was recorded. If stroke volume increased by more than 10 % for 20 minutes, the bolus will be repeated. No further colloid was given once stroke volume failed to increase more than 10% |
all over surgical duration |
The last stroke volume with higher 10% response will be defined as maximum stroke volume (SVmax). When stroke volume decreased intraoperatively by 10% below (SVmax), this will be defined as trigger stroke volume (SVT).Intravenous fluids were infused to maintain stroke volume variation between (8-12 %). If stroke volume variation is less than (8%), I.V crystalloids administration rate was decreased. If stroke volume variation is increased above (12%) I.V crystalloids administration rate was increased .
Blood loss more than 500ml was replaced in 1:1 ratio. Blood loss less than 500 ml was replaced by ringer solution. If there was a reduction in stroke volume below SVt, infusion of 200 ml hydroxy ethyl starch 130/0.4 is started and this infusion was repeated for 3 times before considering giving the patient inotropes according to other cardiac parameters |
50 |
|